Physician profile
Daniel I Ambinder
NPI 1780002741
$32,016.44
in general payments reported to CMS, 2019-2025
21 companies · $3,019 in 2025
The $3,019 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.65 · 2020: $4,000 · 2021: $13K · 2022: $5,916 · 2023: $2,452 · 2024: $3,243 · 2025: $3,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,797 · Travel and Lodging: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,796.64 |
| Travel and Lodging | $917.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,396.62 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $4,557.15 | 2021-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $4,137.40 | 2021-2025 | Mitraclip, Optis, Nc Trek Neo |
| Pfizer INC. | $4,000.00 | 2020 | |
| Boston Scientific Corporation | $771.49 | 2021-2025 | Watchman, Watchman Access System, Watchman Flx |
| Shockwave Medical, INC | $584.02 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $357.29 | 2022-2025 | Impella |
| Chiesi USA, INC. | $267.55 | 2021-2023 | Cleviprex, Kengreal |
| Teleflex LLC | $180.26 | 2023-2024 | Urolift, Guideliner |
| Novo Nordisk INC | $144.63 | 2023 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.46 | 2019-2024 | Lifevest |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Terumo Medical Corporation | $85.77 | 2022-2025 | Metacross Otw, Glidewire, Tr Band |
| Atricure, INC. | $71.57 | 2022-2024 | |
| Philips North America LLC | $51.33 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $33.28 | 2022 | |
| W. L. Gore & Associates, INC. | $30.83 | 2023 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $29.38 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $17.73 | 2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $16.59 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ambinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.